Cargando…

Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer

Immunohistochemistry (IHC) has become an indispensable tool in the clinical practices for breast cancer; however, to achieve its standardization, numerous issues need to be overcome. In this review, we describe the development of IHC as an important clinical tool, and the challenges in standardizing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Shinobu, Nakanishi, Yoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986307/ https://www.ncbi.nlm.nih.gov/pubmed/36890849 http://dx.doi.org/10.1267/ahc.22-00050

Ejemplares similares

Controls for Immunohistochemistry: The Histochemical Society’s Standards of Practice for Validation of Immunohistochemical Assays
por: Hewitt, Stephen M., et al.
Publicado: (2014)

Phylogenetic analysis of combined lobular and ductal carcinoma of the breast
por: Kobayashi, Hiroko, et al.
Publicado: (2021)

Immunohistochemistry in Dermatopathology and its Relevance in Clinical Practice
por: Chatterjee, Debajyoti, et al.
Publicado: (2018)

Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice
por: de Matos, Leandro Luongo, et al.
Publicado: (2010)

Applications of immunohistochemistry
por: Duraiyan, Jeyapradha, et al.
Publicado: (2012)

Improving the State of the Science of Immunohistochemistry: The Histochemical Society’s Standards of Practice
por: Baskin, Denis G., et al.
Publicado: (2014)

Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer
por: Baker, Gabrielle M, et al.
Publicado: (2015)

The pathology of familial breast cancer: Immunohistochemistry and molecular analysis
por: Osin, Pinchas P, et al.
Publicado: (1999)

Digital immunohistochemistry: new horizons and practical solutions in breast cancer pathology
por: Laurinavicius, Arvydas, et al.
Publicado: (2013)

Standardization of PD-L1 immunohistochemistry
por: Martinez-Morilla, Sandra, et al.
Publicado: (2021)

HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer
por: Bae, Young Kyung, et al.
Publicado: (2012)

Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors
por: Takahashi, Yoshihisa, et al.
Publicado: (2021)

p62 Regulates the Proliferation of Molecular Apocrine Breast Cancer Cells
por: Nozaki, Fumi, et al.
Publicado: (2016)

Development of a LAG-3 immunohistochemistry assay for melanoma
por: Johnson, Lori, et al.
Publicado: (2023)

Comparability of PD‐L1 immunohistochemistry assays for non‐small‐cell lung cancer: a systematic review
por: Koomen, Bregje M, et al.
Publicado: (2020)

Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy
por: Yeong, Joe, et al.
Publicado: (2022)

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma
por: Chapel, David B., et al.
Publicado: (2020)

Breast cancer in togolese women: immunohistochemistry subtypes
por: Adani-Ifè, Ablavi, et al.
Publicado: (2020)

Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study
por: Liu, Wen-Lou, et al.
Publicado: (2015)

Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH
por: Lotan, Tamara L., et al.
Publicado: (2016)

“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
por: Torlakovic, Emina, et al.
Publicado: (2019)

Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes
por: Iizuka, Misato, et al.
Publicado: (2015)

Update on Immunohistochemistry for the Diagnosis of Lung Cancer
por: Inamura, Kentaro
Publicado: (2018)

Generation of monoclonal antibodies against MGA and comparison of their application in breast cancer detection by immunohistochemistry
por: Duan, Cuimi, et al.
Publicado: (2015)

Bladder mucosa-associated lymphoid tissue lymphoma progressed from chronic cystitis along with a comparative genetic analysis during long-term follow-up: a case report
por: Ishibashi, Naoya, et al.
Publicado: (2021)

Quantitative Assessment of PD-L1 as an Analyte in Immunohistochemistry Diagnostic Assays using a Standardized Cell Line Tissue Microarray
por: Martinez-Morilla, Sandra, et al.
Publicado: (2019)

Altered Immunohistochemical Expression Patterns of HLA Class I during the Clinical Course of Cervical Intraepithelial Neoplasia
por: Koguchi, Okuto, et al.
Publicado: (2021)

Roles of Ras Homolog A in Invasive Ductal Breast Carcinoma
por: Murakami, Eriko, et al.
Publicado: (2016)

Assessment of breast cancer immunohistochemistry and tumor characteristics in Nigeria
por: Aliyu, Usman Malami, et al.
Publicado: (2020)

Insulin Assay Standardization: Leading to measures of insulin sensitivity and secretion for practical clinical care
por: Staten, Myrlene A., et al.
Publicado: (2010)

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
por: Uruga, Hironori, et al.
Publicado: (2018)

What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms
por: Koopman, Timco, et al.
Publicado: (2019)

Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay
por: Goud, Kalal Iravathy, et al.
Publicado: (2012)

PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer
por: Rugo, Hope S, et al.
Publicado: (2021)

Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability
por: Ahn, Soomin, et al.
Publicado: (2021)

HER2 classification in breast cancer cells: A new explainable machine learning application for immunohistochemistry
por: Cordova, Claudio, et al.
Publicado: (2022)

Tissue Thickness Interferes With the Estimation of the Immunohistochemical Intensity: Introduction of a Control System for Managing Tissue Thickness
por: Masuda, Shinobu, et al.
Publicado: (2021)

Cell-blocks and immunohistochemistry
por: Shidham, Vinod B., et al.
Publicado: (2021)

p53 Status in Multiple Human Urothelial Cancers: Assessment for Clonality by the Yeast p53 Functional Assay in Combination with p53 Immunohistochemistry
por: Yamamoto, Shinji, et al.
Publicado: (2000)

The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
por: Klevesath, M B, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_jkjm5q83eum17k7pgn7fc48tb7